Benzinga | May 10, 2021 04:40PM EDT

Aligos Therapeutics Q1 EPS $(0.74) Beats $(0.90) Estimate, Sales $910.00K

Aligos Therapeutics (NASDAQ:ALGS) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.90) by 17.78 percent. The company reported $910.00 thousand in sales this quarter.